Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial (Q73632597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

title

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

5

Alfred P Hallstrom

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

author name string

L Brent Mitchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

Judy L Powell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

Anne M Gillis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

Victoria Kehl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

AVID Investigators

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

81-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Range of serum cholesterol values in the population developing coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Importance of endothelial function in mediating the benefits of lipid-lowering therapy.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Endothelial function and cardiovascular prevention: role of blood lipids, exercise, and other risk factors

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Myocardial ischemia: what factors determine arrhythmogenesis?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

Influence of dietary fat on the pharmacodynamics of propafenone in isolated, perfused rabbit hearts

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)00498-4

7 January 2021

10.1016/S0735-1097(03)00498-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849664 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference